DJ AstraZeneca PLC ADR Falls Monday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ slid 3.90% to $65.79 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.10% to 15,603.26 and the Dow Jones Industrial Average falling 0.91% to 37,965.60.
This was the ADR's second consecutive day of losses.
AstraZeneca PLC ADR closed 24.96% below its 52-week high of $87.68, which the company reached on August 30th.
The ADR underperformed when compared to some of its competitors Monday, as Eli Lilly & Co. $(LLY)$ fell 1.96% to $723.73, Biogen Inc. $(BIIB)$ fell 3.08% to $119.19, and Johnson & Johnson $(JNJ)$ fell 1.71% to $150.62.
Trading volume (11.9 M) eclipsed its 50-day average volume of 5.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 7, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 07, 2025 17:22 ET (21:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.